Exact Mass: 555.2176
Exact Mass Matches: 555.2176
Found 114 metabolites which its exact mass value is equals to given mass value 555.2176
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Demethyldecarbamoylnovobiocin
A hydroxycoumarin that is novobiocin lacking the 3-O-carbamoyl and 4-O-methyl groups from the hexose ring.
15-Demethylaclacinomycin T
An anthracycline obtained by hydrolysis of the methyl ester group of aclacinomycin T.
Rociletinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Isoflavone base + 1O, 1MeO, O-Hex+C7H12NO
Annotation level-3
2-amino-5-[(5-beta-D-glucopyranosyl-4-hydroxy-cyclopent-2-enylamino)-methyl]-7-beta-D-ribofuranosyl-3,7-dihydro-pyrrolo[2,3-d]pyrimidin-4-one
Cys Asp Arg Tyr
Cys Asp Tyr Arg
Cys Phe Thr Trp
Cys Phe Trp Thr
Cys Arg Asp Tyr
Cys Arg Tyr Asp
Cys Thr Phe Trp
Cys Thr Trp Phe
Cys Trp Phe Thr
Cys Trp Thr Phe
Cys Tyr Asp Arg
Cys Tyr Arg Asp
Asp Cys Arg Tyr
Asp Cys Tyr Arg
Asp Arg Cys Tyr
Asp Arg Tyr Cys
Asp Tyr Cys Arg
Asp Tyr Arg Cys
Phe Cys Thr Trp
Phe Cys Trp Thr
Phe Met Met Gln
Phe Met Gln Met
Phe Gln Met Met
Phe Thr Cys Trp
Phe Thr Trp Cys
Phe Trp Cys Thr
Phe Trp Thr Cys
Gly Met Trp Tyr
Gly Met Tyr Trp
Gly Trp Met Tyr
Gly Trp Tyr Met
Gly Tyr Met Trp
Gly Tyr Trp Met
Met Phe Met Gln
Met Phe Gln Met
Met Gly Trp Tyr
Met Gly Tyr Trp
Met Met Phe Gln
Met Met Gln Phe
Met Gln Phe Met
Met Gln Met Phe
Met Trp Gly Tyr
Met Trp Tyr Gly
Met Tyr Gly Trp
Met Tyr Trp Gly
Gln Phe Met Met
Gln Met Phe Met
Gln Met Met Phe
Arg Cys Asp Tyr
Arg Cys Tyr Asp
Arg Asp Cys Tyr
Arg Asp Tyr Cys
Arg Tyr Cys Asp
Arg Tyr Asp Cys
Thr Cys Phe Trp
Thr Cys Trp Phe
Thr Phe Cys Trp
Thr Phe Trp Cys
Thr Trp Cys Phe
Thr Trp Phe Cys
Trp Cys Phe Thr
Trp Cys Thr Phe
Trp Phe Cys Thr
Trp Phe Thr Cys
Trp Gly Met Tyr
Trp Gly Tyr Met
Trp Met Gly Tyr
Trp Met Tyr Gly
Trp Thr Cys Phe
Trp Thr Phe Cys
Trp Tyr Gly Met
Trp Tyr Met Gly
Tyr Cys Asp Arg
Tyr Cys Arg Asp
Tyr Asp Cys Arg
Tyr Asp Arg Cys
Tyr Gly Met Trp
Tyr Gly Trp Met
Tyr Met Gly Trp
Tyr Met Trp Gly
Tyr Arg Cys Asp
Tyr Arg Asp Cys
Tyr Trp Gly Met
Tyr Trp Met Gly
Rucaparib Camsylate
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor C471 - Enzyme Inhibitor
N-(Ethylsulfonyl)tryptophyl-N~1~-{4-[amino(imino)methyl]benzyl}glutamamide
Rociletinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EB - Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163952 - EGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
(7,7-Dimethyl-2-oxo-1-bicyclo[2.2.1]heptanyl)methanesulfonic acid;6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one
(1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylazaniumyl)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[[(1S,2R,4R,7Z,11S)-4,8-dimethyl-13-oxo-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-12-yl]methylsulfanyl]-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
3-(4-fluorophenyl)-1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-8-(2-methylphenyl)-1,1-dioxo-4,5-dihydro-3H-6,1$l^{6},2-benzoxathiazocin-5-yl]methyl]-1-methylurea
15-demethylaclacinomycin T zwitterion
A zwitterion obtained by transfer of a proton from the carboxy to the tertiary amino group of 15-demethylaclacinomycin T.
3-vinylbacteriochlorophyllide d(1-)
A cyclic tetrapyrrole anion that is the conjugate base of 3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.